Exosome Diagnostics Receives $20,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=96079754-1491-4966-973d-d36084bc7af9&Preview=1 -
Date
5/12/2010 -
Company Name
Exosome Diagnostics -
Mailing Address
3960 Broadway New York, NY 10032 -
Company Description
Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. -
Website
http://www.ExosomeDX.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The purpose of the funding will be to further develop and commercialize a series of next-generation body fluid based oncology diagnostics through its proprietary, exosome based technology platform. -
M&A Terms
-
Venture Investor
NGN Capital -
Venture Investor
NGN Capital -
Venture Investor
Forbion Capital Partners
